Neurotherapeutics
Neurotherapeutics is a quarterly peer-reviewed medical journal covering research on experimental treatments of neurological disorders. It was established in 2004 and is published by Springer Science+Business Media on behalf of the American Society for Experimental NeuroTherapeutics. The editor-in-chief is Maral Mouradian (Robert Wood Johnson Medical School). The founding editor-in-chief was Alan I. Faden (University of Maryland School of Medicine).
 | |
| Discipline | Neurology |
|---|---|
| Language | English |
| Edited by | Maral Mouradian |
| Publication details | |
| History | 2004-present |
| Publisher | Springer Science+Business Media on behalf of the American Society for Experimental NeuroTherapeutics |
| Frequency | Quarterly |
| 5.719 (2017) | |
| Standard abbreviations | |
| ISO 4 | Neurotherapeutics |
| Indexing | |
| ISSN | 1933-7213 (print) 1878-7479 (web) |
| LCCN | 2006215616 |
| OCLC no. | 82448136 |
| Links | |
Abstracting and indexing
The journal is abstracted and indexed in:
- Science Citation Index Expanded
- Index Medicus/PubMed/MEDLINE
- Scopus
- PsycINFO
- EMBASE
- Chemical Abstracts Service
- EBSCO databases
- Academic OneFile
- Current Contents/Life Sciences
- Current Contents/Clinical Medicine
According to the Journal Citation Reports, the journal has a 2017 impact factor of 5.719.[1]
gollark: I'm insulting nobody in particular, see.
gollark: Continue "helping".
gollark: No, I'm just testing.
gollark: You should feel very insulted right now.
gollark: Link established.
References
- "Neurotherapeutics". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.
External links
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.